ft516
Cell therapyexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2019 (NCT04023071)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Natural killer cellSupplementation
Natural killer cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04630769 | Phase 1 | Apr 2, 2021 | University of Minnesota |
| NCT04551885 | Phase 1 | Sep 7, 2020 | Fate Therapeutics |
| NCT04363346 | Phase 1 | May 14, 2020 | University of Minnesota |
| NCT04023071 | Phase 1 | Sep 30, 2019 | Fate Therapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fate Therapeutics | For profit | 2 | 2 | 1 | 2019 |
| University of Minnesota | Academic/Hospital | 2 | 2 | 1 | 2020 |
2 organizations
Page 1 / 1